The seemingly conflicting effects of GIP on body weight will be discussed further in later sections
In addition, a large-scale clinical study demonstrated that GLP-1 analogues could reduce the mortality of patients with prostate cancer and diabetes (210, 224)
These findings have provided valuable insights into the management of T2D and informed clinical practice guidelines and regulatory decisions.GLP-1 receptor agonists have emerged as an important therapeutic option for individuals with T2D, particularly those at high risk of CVD
The sympathetic nerves release norepinephrine, which activates receptors on adipocytes, leading to the mobilization of stored triglycerides
"At one year, weight loss is about 8%, but by three years, it's gone down to 6%," he says
Nephroprotection with saxagliptin